Literature DB >> 7614728

Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro.

P VanBuren1, D E Harris, N R Alpert, D M Warshaw.   

Abstract

The two mammalian cardiac myosin heavy chain isoforms, alpha and beta, have 93% amino acid homology, but hearts expressing these myosins exhibit marked differences in their mechanical activities. To further understand the function of these cardiac myosins as molecular motors, we compared the ability of these myosins to hydrolyze ATP and to both translocate actin filaments and generate force in an in vitro motility assay. V1 myosin has twice the actin-activated ATPase activity and three times the actin filament sliding velocity when compared with V3 myosin. In contrast, the force-generating ability of these myosins is quite different when the total force produced by a small population of myosin molecules (> 50) is examined. V1 myosin produces only one half the average cross-bridge force of V3 myosin. With discrete areas of primary structural heterogeneity known to exist between alpha and beta heavy chains, the differences we report in the hydrolytic and mechanical activities of the motors are explored in the context of potential structural and kinetic differences between the V1 and V3 myosins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614728     DOI: 10.1161/01.res.77.2.439

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  64 in total

1.  Kinetic differences at the single molecule level account for the functional diversity of rabbit cardiac myosin isoforms.

Authors:  K A Palmiter; M J Tyska; D E Dupuis; N R Alpert; D M Warshaw
Journal:  J Physiol       Date:  1999-09-15       Impact factor: 5.182

2.  Functional diversity between orthologous myosins with minimal sequence diversity.

Authors:  M Canepari; R Rossi; M A Pellegrino; R Bottinelli; S Schiaffino; C Reggiani
Journal:  J Muscle Res Cell Motil       Date:  2000-05       Impact factor: 2.698

3.  Mammalian cardiac muscle thick filaments: their periodicity and interactions with actin.

Authors:  Robert W Kensler
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

Review 4.  Variable surface loops and myosin activity: accessories to a motor.

Authors:  C T Murphy; J A Spudich
Journal:  J Muscle Res Cell Motil       Date:  2000-02       Impact factor: 2.698

5.  A simple method for measuring the relative force exerted by myosin on actin filaments in the in vitro motility assay: evidence that tropomyosin and troponin increase force in single thin filaments.

Authors:  W Bing; A Knott; S B Marston
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

6.  Heterologous expression of wild-type and mutant beta-cardiac myosin changes the contractile kinetics of cultured mouse myotubes.

Authors:  Gaynor Miller; Joanne Maycock; Ed White; Michelle Peckham; Sarah Calaghan
Journal:  J Physiol       Date:  2003-02-07       Impact factor: 5.182

7.  Sildenafil reverses the hypertrophy of mice right ventricle caused by hypoxia but does not reverse the changes in the myosin heavy chain isoforms.

Authors:  Mukhallad A Aljanabi; Mahmoud A Alfaqih; Anwar Mohammad A Al-Khayat; Hameed N Bataineh
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-06-15

Review 8.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

9.  Auto-oscillations of skinned myocardium correlating with heartbeat.

Authors:  Daisuke Sasaki; Hideaki Fujita; Norio Fukuda; Satoshi Kurihara; Shin'ichi Ishiwata
Journal:  J Muscle Res Cell Motil       Date:  2005-07-01       Impact factor: 2.698

10.  Removal of the N-terminal extension of cardiac troponin I as a functional compensation for impaired myocardial beta-adrenergic signaling.

Authors:  Han-Zhong Feng; Min Chen; Lee S Weinstein; Jian-Ping Jin
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.